- Research article
- Open Access
Focal Adhesion Kinase contributes to insulin-induced actin reorganization into a mesh harboring Glucose transporter-4 in insulin resistant skeletal muscle cells
BMC Cell Biologyvolume 9, Article number: 48 (2008)
Focal Adhesion Kinase (FAK) is recently reported to regulate insulin resistance by regulating glucose uptake in C2C12 skeletal muscle cells. However, the underlying mechanism for FAK-mediated glucose transporter-4 translocation (Glut-4), responsible for glucose uptake, remains unknown. Recently actin remodeling was reported to be essential for Glut-4 translocation. Therefore, we investigated whether FAK contributes to insulin-induced actin remodeling and harbor Glut-4 for glucose transport and whether downregulation of FAK affects the remodeling and causes insulin resistance.
To address the issue we employed two approaches: gain of function by overexpressing FAK and loss of function by siRNA-mediated silencing of FAK. We observed that overexpression of FAK induces actin remodeling in skeletal muscle cells in presence of insulin. Concomitant to this Glut-4 molecules were also observed to be present in the vicinity of remodeled actin, as indicated by the colocalization studies. FAK-mediated actin remodeling resulted into subsequent glucose uptake via PI3K-dependent pathway. On the other hand FAK silencing reduced actin remodeling affecting Glut-4 translocation resulting into insulin resistance.
The data confirms that FAK regulates glucose uptake through actin reorganization in skeletal muscle. FAK overexpression supports actin remodeling and subsequent glucose uptake in a PI3K dependent manner. Inhibition of FAK prevents insulin-stimulated remodeling of actin filaments resulting into decreased Glut-4 translocation and glucose uptake generating insulin resistance. To our knowledge this is the first study relating FAK, actin remodeling, Glut-4 translocation and glucose uptake and their interrelationship in generating insulin resistance.
The uptake of glucose by skeletal muscle, a major insulin responsive organ, is mediated by the insulin-responsive glucose transporters, Glut-4 [1, 2]. Insulin stimulation elicits Glut-4 recruitment to the plasma membrane of skeletal muscle thereby increasing glucose influx [3, 4]. Under insulin resistant condition, loss of this response triggers an elevation of circulating insulin, resulting into hyperinsulinemia. This worsens insulin resistance resulting into type 2 diabetes [5–7]. Therefore, an in-depth study of insulin signaling at the cellular and molecular level is critical to understand the pathogenesis of type 2 diabetes.
In order to better understand insulin resistance at a molecular level we have previously developed an insulin resistant skeletal muscle cell model by differentiating C2C12 skeletal muscle cells in chronic presence (MFI) and absence (MF) of insulin in serum free medium . The model mimics the physiological insulin resistant condition of skeletal muscle. Using the model system we have recently reported involvement of Focal Adhesion Kinase (FAK), a cytosolic non-receptor protein tyrosine kinase, in the regulation of insulin resistance in C2C12 skeletal muscle by modulating glucose uptake . The study established that under insulin resistant condition overexpression of FAK enhanced insulin-mediated glucose uptake. However, no change in the expression of Glut-4 was observed due to overexpression of FAK, thereby leaving an important unresolved issue of how FAK regulates glucose uptake under insulin resistant condition.
Recent reports suggest that insulin induces remodeling of actin filaments, in myotubes [10, 11], adipocytes [12, 13] and fibroblasts  under normal physiological conditions. Moreover, disruption of actin cytoskeleton was also reported to prevent translocation of Glut-4 to the cell surface of muscle [10, 15–17]. In fibroblasts FAK was reported to stabilize microtubules and its tyrosine kinase activity was reported to play an important role in the rearrangement of actin fibers in CHO/IR cells [18–20]. Recently it was reported that Fak-null keratinocytes display an aberrant actin cytoskeleton, which is tightly associated with focal adhesions and microtubules .
Therefore, in the light of the above literature, we sought out to determine whether FAK regulates glucose uptake by altering actin filament dynamics and Glut-4 translocation, in insulin responsive and resistant skeletal muscle cells.
Insulin-mediated colocalization of FAK with remodeled actin
In order to investigate the role of FAK in regulating insulin-induced actin remodeling and subsequent Glut-4 translocation, if any, we examined the effect of insulin on the distribution and localization of FAK and actin cytoskeleton rearrangements in insulin sensitive and resistant skeletal muscle cells. C2C12 skeletal muscle cells were differentiated under insulin sensitive (MF) and insulin resistant (MFI) conditions, stimulated with or without insulin (30 min with 100 nM insulin), immunostained with anti-FAK antibody and phalloidin Texas Red and were observed under a confocal microscope (Fig. 1). Immunocytochemical analysis revealed that under basal condition (in absence of insulin stimulation) FAK colocalized with actin filaments only at the site of adhesion of insulin sensitive skeletal muscle cells (MF) (Fig. 1, panel a). However insulin stimulation caused remodeling of actin filaments into a cortical mesh (Fig. 1, panel b, red) and FAK was found to be redistributed and colocalized with remodeled actin filaments, (Fig. 1, panel b) as compared to unstimulated cells. The observed phenomenon of cellular colocalization between FAK and actin was elucidated by colocalization graph (two color scatter plot) plotted between the green and red color intensity pixels by EZ Viewer software (Fig. 2). Colocalization graph under MF condition showed no colocalization between FAK and actin at the cortex as indicated by the pixels present distributed along x and y axis (Fig. 2, panel a). However, significant colocalization was observed in the cortical section after insulin stimulation (Fig. 2, panel b).
On the other hand, in insulin resistant skeletal muscle (MFI), neither actin remodeling nor redistribution of FAK was observed with or without insulin stimulation (Fig. 1, panel c, d). No colocalization was observed between FAK and actin at the cortical sites (Fig. 2, panel c, d). Taken together, these results indicate that in insulin sensitive skeletal muscle cells insulin stimulation causes redistribution of FAK leading to its colocalization with remodeled actin filaments. However, no such event takes place in insulin resistant cells.
Effect of modulation of FAK expression on actin remodeling and Glut-4 translocation
Previously we have reported that overexpression of FAK increases insulin-stimulated glucose uptake without altering Glut-4 expression , thereby, pointing to a possibility of enhanced Glut-4 translocation. In order to investigate the significance of FAK and actin colocalization on subsequent translocation of Glut-4 in skeletal muscle, we had generated a C2C12 skeletal muscle stable cell line overexpressing Green Florescence Protein (GFP) tagged Glut-4 molecules (C2Glut-4wt/+, see Additional file 1). In order to establish that overexpressed GFP-Glut-4 cycles and respond to insulin in a manner similar to endogenous Glut-4, transfected cells were differentiated and stimulated with or without insulin and Glut-4 translocation was examined by confocal microscopy (see Additional file 2). Positive response of the transporters to insulin stimuli suggested the existence of functional Glut-4 translocation machinery. Our observation is in coherence with the previous report suggesting that C2C12 myotubes were equipped with the basic Glut-4 translocation machinery and could be activated by insulin . Thus proposes the above cell line as a useful model for analyzing Glut-4 translocation in skeletal muscle.
To further investigate the participation of FAK in actin remodeling, two approaches were used: gain of function by increasing the expression of FAK and loss of function by specifically knocking down the expression of FAK. For overexpression C2Glut-4wt/+ cells were transfected with a plasmid containing the wild type FAK gene (C2Glut-4wt/+FAKwt/+) and knocked down by using a FAK specific siRNA (C2Glut-4wt/+FAKwt/-). The FAK specific siRNA sequences were designed by Quiagen GmbH (Germany) and have been utilized previously in our laboratory to specifically inhibit FAK expression in C2C12 skeletal muscle cells . To determine the extent of overexpression, cells were differentiated, lysed and subjected to westernimmunoblotting, probed with anti-FAK antibody (see Additional file 3) and compared with the untransfected control. The significant amount of overexpression (more than 70%, see Additional file 3, lane 3 vs lane 1) of FAK was observed. An additional data on silencing of FAK by siRNA (more than 90%, see Additional file 3, lane 4 vs lane 1) has also been presented. Thus, various cell models (over and under expressing FAK and over expressing Glut-4) were generated and validated, for investigating FAK-mediated effect of insulin on actin remodeling and Glut-4 translocation.
FAK untransfected (C2Glut-4wt/+) and transfected (C2Glut-4wt/+FAKwt/+ and C2Glut-4wt/+FAKwt/-) cells were differentiated under MF and MFI conditions and stimulated with and without insulin and subjected to immunoflorescence microscopy. In absence of insulin stimulation, MF cells expressing end ogenous level of FAK showed long actin filaments and no colocalization between actin and Glut-4 at the cortical region (Fig. 3, panel A). (For easier comparison only merge images are shown. For complete panel (GFP, Phalloidin, DAPI and Merge) see Additional file 4, panel A). No significant change in the structure of actin filaments and Glut-4 molecules were observed in cells with underexpressed FAK (Fig. 3, panel C and see Additional file 6, panel A). A small amount of actin remodeling was observed with cells overexpressing FAK (Fig. 3, panel B) but this was not significant as compared to what was observed after insulin stimulation. Whereas after insulin stimulation, actin was found to be reorganized at the perinuclear region upward into a mesh-like structure showing colocalized Glut-4 molecules (Fig. 3, panel D and see Additional file 4, panel B). Interestingly, the extent of actin remodeling after insulin stimulation was found to be significantly increased in FAK overexpressed cells (Fig. 3, panel E and see Additional file 5, panel B) as compared to C2Glut-4wt/+ cells (Fig. 3, panel E vs. Fig 3, panel D). In presence of insulin, overexpression of FAK reorganized filamentous actin into a mesh-like structure (see Additional file 5, panel B). In addition, a huge amount of colocalized Glut-4 molecules were also observed in the same section of the remodeled actin. Data suggest that overexpression of FAK enhances insulin-mediated actin remodeling and remodeled actin harbors the Glut-4 molecules which eventually facilitate the translocation of these transporters to the plasma membrane. Consistent to the previous report of Li et al., , we did not observe a clear shift of Glut-4 molecule to perinuclear region forming a tighter ring as observed in adipocytes after insulin stimulation [24, 25]. In contrast to the C2Glut-4wt/+ cells, FAK silenced cells did not show actin remodeling (Fig. 3, panel F) thus, further confirming the role of FAK in governing actin dynamics.
Under insulin resistant condition (MFI) no actin remodeling was observed in C2Glut-4wt/+ cells (Fig. 3, panel G, see Additional file 4, panel C). C2Glut-4wt/+FAKwt/+ and C2Glut-4wt/+FAKwt/- cells did not show any significant change in actin dynamics (Fig. 3, panel H and I). Even after insulin stimulation C2Glut-4wt/+ cells under MFI condition did not show any alteration of actin dynamics (Fig. 3, panel J). However, overexpression of FAK under MFI condition augmented actin remodeling after insulin stimulation (Fig. 3, panel K) but lesser than that observed under MF condition (Fig. 3, panel K vs. Fig. 3, panel E). These results are consistent with our previous reports that, insulin stimulation causes enhanced glucose uptake under MF as well as in MFI condition in FAK overexpressing cells . The data suggests that overexpression of FAK under insulin resistant condition alters insulin-mediated actin remodeling and thereby regulates glucose uptake by differentially harbouring Glut-4 molecules. Under FAK silenced condition (C2Glut-4wt/+FAKwt/-cells), the insulin-mediated additional Glut-4 redistribution, actin remodeling, and colocalization were largely abolished in MFI condition (Fig. 3, panel L). The data thus strongly suggests that FAK regulate insulin-mediated actin remodeling into a mesh harboring Glut-4 molecules.
Role of Phosphatidylinositol-3 Kinase (PI3K) in FAK-mediated regulation of actin remodeling
Earlier we had reported that FAK silencing develops insulin resistance via inactivation of PI3K activity . Altered expression of FAK was observed to modulate actin dynamics, hence, we examined whether FAK regulates actin remodeling and subsequent Glut-4 translocation in a PI3K-dependent pathway. To determine this, the downstream pathway was disrupted by inhibiting PI3K activity using wartmanin (WM). C2Glut-4FAKwt/+ cells were treated with wartmanin (WM), stimulated with insulin, stained for actin and subjected to fluorescence microscopy. We observed significant amount of remodeling in C2Glut-4FAKwt/+ cells after insulin stimulation under both MF and MFI conditions (Fig. 4, panel a, c), whereas WM treatment abolished the observed effect (Fig. 4, panel b, d). To further substantiate the effect of WM, glucose uptake of C2Glut-4FAKwt/+ cells was assayed under MF and MFI condition. As a result of WM treatment a significant decrease (53.3 ± 0.34%) in insulin-stimulated glucose uptake (Fig. 5, lane 3 vs. 2; P < 0.01) was observed and was not restored even after insulin stimulation (Fig. 5, lane 4 vs. 2; P < 0.01) under MF and MFI conditions. Therefore, FAK regulates insulin-induced actin remodeling harboring Glut-4 in a PI3K-dependent pathway in insulin responsive and resistant cell lines. Data provides mechanistic insight of FAK-mediated regulation of insulin resistance.
Huang et al.,  has recently reported that reducing FAK expression results into "fewer stress fibers" and "scarce focal adhesion complexes" under normal insulin signaling and proposed a probable theoretical signaling cascade linking FAK, actin and Glut-4. However, the interrelationship between FAK, actin dynamics and Glut-4 translocation remains unaddressed as is the direct proof on FAK's possible role in cascading actin dynamics and Glut-4 translocation in regulating insulin resistance. It is well recognised that insulin causes a rapid and marked "remodeling" of actin filaments, in different cells like myotubes , adipocytes [12, 27, 28] and fibroblasts [15, 18] for the translocation of Glut-4 molecules. Therefore, it is not the number of stress fibers, as observed by Huang et al.,  it is the actin remodeling which is considered as the biophysical interacting module by which the probable interaction between actin and Glut-4 translocation is brought into reality. Regulation of glucose uptake in muscle cells via Glut-4 is a fundamental action of insulin and gets disrupted in insulin resistance. As the disease is expanding in epidemic proportions, understanding the molecular basis of Glut-4 translocation especially under the insulin resistant condition is paramount. Hence, the present study was designed to explore the fundamentally unresolved issue of how FAK regulates Glut-4 translocation and thereby establishes the biological function of FAK in both insulin responsive and resistant cell lines. This has been explored by overexpression of FAK and perturbing endogenous FAK expression. We observed the following: (i) FAK regulates insulin-stimulated "actin remodeling" leading to Glut-4 translocation (ii) inhibition of FAK prevents actin remodeling and decreases glucose uptake, (iii) under insulin resistant condition, overexpression of FAK induces insulin-stimulated actin remodeling, colocalization with Glut-4 prior to translocation and (iv) PI3K is upstream to actin colocalization. Therefore we are reporting for the first time, a pathophysiological role of FAK-mediated actin remodeling induced Glut-4 translocation and glucose uptake in both insulin responsive and resistant cell lines.
Several laboratories have suggest that cytoskeletal mechanics plays an essential role in insulin-dependent Glut-4 translocation . Studies examining the role of actin cytoskeleton in this process in L6 myotubes and adipocytes have shown that disruption of actin cytoskeleton inhibits insulin-mediated Glut-4 translocation [10, 28]. Recently, cytoskeletal abnormalities were reported in insulin resistant skeletal muscle cells . Though, growth factor-induced role of FAK with actin was also reported where increased FAK tyrosine phosphorylation was observed to enhance the formation of actin stress fibers in Chinese Hamster Ovary cells overexpressing the human insulin receptor (CHO/IR). But no physiological role of FAK tyrosine phosphorylation linking actin reorganization was reported . FAK was also reported to regulate cellular morphology via actin cytoskeleton in acinar cells . FAK prompted p190Rho-GEF tyrosine phosphorylation after integrin or growth factor stimulation in neuro2A cells, which activates actin stress fiber formation leading to morphological changes in actin cytoskeleton . However, to the best of our knowledge, no study was available establishing the role of FAK in altering actin remodeling and subsequent Glut-4 translocation in insulin resistant condition.
Previous studies indicate that insulin stimulation rearranges filamentous actin into mesh-like structures at the cortex . However, the nature and characteristics of actin filament remodeling has not been elucidated earlier. In the present study we observed that although FAK normally localized at the focal adhesions and colocalized with actin at the growing ends of cells. However, after insulin stimulation FAK was redistributed and were found to be colocalized at the site of remodeled actin. Colocalization of FAK with remodeled actin shows that remodeled filaments with actively growing ends govern rapid polymerization/depolymerization as molecular motors which function as a conveyor belt translocating Glut-4. It has been previously reported that insulin facilitates the association of PI3K with Glut-4 vesicles by inducing actin remodeling and recruits Glut-4 to the plasma membrane . Our observation indicates that after insulin stimulation FAK localizes to the actin remodeling sites which acts as a hub providing a platform for insulin signalling proteins (e.g. PI3K etc) for interaction. This in turn facilitates Glut-4 translocation. Our study thus provides a conceptual advancement regarding the cellular localization and distribution of FAK with the remodeled actin filaments and its connectivity with glucose uptake.
Previous reports suggest that insulin modulates actin dynamics in PI3K-dependent and -independent ways [34–37]. We have previously reported that FAK regulates insulin signaling by altering the activity of PI3K . Downstream to PI3K a divergence of signal takes place where signal passes primarily through PKC . Our present study demonstrates that FAK regulates Glut-4 translocation through PI3K. A recent study of Liu et al.,  has reported involvement of PKC in insulin-induced glucose transport through actin remodeling. Therefore, considering all these studies together we propose that FAK regulates insulin signaling through activation of IRS-1, PI3K, Akt, PKC, actin remodeling, Glut-4 translocation and glucose uptake (see Additional file 7).
Hence, the present study provides insights to the molecular mechanism of FAK-mediated Glut-4 translocation and glucose uptake via actin remodeling and its correlation with the pathophysiology of insulin resistance in skeletal muscle, a tissue responsible for 80% of postprandial glucose disposal and a major peripheral site of insulin resistance in diabetes. Extrapolating the finding of the study we can conclude that overexpression/activation of FAK under resistance condition can be a potential therapeutic approach towards insulin resistance.
DMEM and trypsin-EDTA were purchased from Gibco BRL (Grand Island, NY). FCS was from Biological Industries (Kibbutz Beit, Haemek, Israel). Nutrient Mixture F-12 Ham, MCDB 201 medium, BSA (cell culture grade), [3H]2-deoxyglucose (2DOG), TEMED, anti-rabbit, anti-mouse IgG alkaline phosphatase and FITC conjugated were from Sigma Chemical Company (MO, USA). Anti-FAK antibody was from Santa Cruz Biotechnology (CA, USA). Bovine insulin, wartmanin and anti-Glut-4 antibody was purchased from Calbiochem (CA, USA). 4,6-diamidino-2-phenylindole (DAPI), Phalloidin Texas Red were purchased from Molecular Probes, Inc. TransFast transfection reagent was from Promega (Madison, WI). RNAifect transfecton reagent was from Qiagen GmbH (Germany). All the other reagents unless attributed specifically were from Sigma Chemical Company.
C2C12 skeletal muscle (wild-type and transfectants) were maintained in DMEM supplemented with 15% FCS (containing penicillin 100 IU/ml, streptomycin 100 μg/ml) in 5% CO2 at 37°C. 70% confluent cells were differentiated in an equal mixture of MCDB 201 and Ham's F-12 medium in absence (MF: insulin sensitive) or in chronic presence of 100 nM insulin (MFI: insulin resistant) for 3 days .
Transfection of plasmid vectors
C2C12 cells were transfected with pcDNA3-GFP-Glut-4 plasmid and pcDNA3.1-HA-FAKwt plasmid using TransFast transfection reagent as describe earlier .
siRNA oligonucleotides against FAK targeted sequence 5'-TGCAATGGAACGAGTATTAAA-3', designed and synthesized by Qiagen GmbH (Germany) were transfected (400 nM) in C2C12 cells using RNAifect transfection reagent in reduced serum Opti-MEM as describe earlier .
Cell lysis and westernimmunoblotting
Cells were washed with ice cold PBS and lysed in lysis buffer and equal concentration of lysates was subjected to SDS-PAGE followed by westernimmunoblotting as reported before .
Fluorescence and Confocal Laser Microscopy
Immunofluorescence studies of C2C12 cells (transfected and untransfected) were carried out as described previously [11, 38]. Briefly, myotubes were subjected to starvation for 4 h and treated with 100 nM insulin for 30 min at 37°C. Cells were fixed with 2% paraformaldehyde in 0.1 M sodium phosphate buffer, pH 7.3 for 30 min. Cells were washed in PBS containing 1% BSA and blocked using blocking buffer (BSA 1%, goat serum 2% in PBS) for 30 min. Cells were permeabilized by incubating with 0.2% Triton X-100 for 10 min, followed by washing with PBS/BSA solution. Cells were incubated with anti-FAK antibody for 2 h at room temperature. Bound antibody was visualized under microscope (Nikon, Tokyo, Japan) by incubating with secondary antibody labeled with FITC. For labeling of actin filaments, fixed and permeabilized cells were incubated for 1 h at room temperature with Phalloidin Texas Red (0.01 U/coverslip). To assess autofluorescence, additional samples were treated for 1 h with PBS without labeled phalloidin. For nuclear staining, cells were labeled with 600 nM DAPI in PBS for 5 min at room temperature. Cells were washed further with PBS and mounted in mowiol on to glass slides. Digital micrographs were taken using a Nikon camera mounted on Nikon E600 microscope using 60 × confocal objective. Images were processed using Image-Pro Express (Media Cybernetics, Madison, U.S.A.), EZ Viewer and Adobe Photoshop 5.5 (Adobe Systems Inc., CA, U.S.A.) software. At least 10 microscopic fields were observed for each sample.
Glucose uptake assay
Glucose uptake assays were performed using 2-DOG as earlier described .
Data are expressed as mean ± SEM. For comparison of two groups, P-values were calculated by two-tailed unpaired student's t-test. In all cases P < 0.05 was considered to be statistically significant.
focal adhesion kinase. PI3K: phosphatidylinositol 3'-kinase. GFP: green fluorescent protein. DAPI: 4,6-diamidino-2-phenylindole. 2DOG: [3H]2-deoxyglucose. Glut-4: Glucose transporter-4. siRNA: small interfering RNA. WM: wartmanin.
Huang S, Czech MP: The GLUT4 glucose transporter. Cell Metab. 2007, 5: 237-252. 10.1016/j.cmet.2007.03.006.
Ryder WJ, Gilbert M, Zierath JR: Skeletal muscle and insulin sensitivity: pathophysiological alterations. Front in Biosci. 2001, 6: d154-d163. 10.2741/Ryder.
Thong FSL, Dugani CB, Klip A: Turning signals on and off: GLUT4 traffic in the insulin-signaling highway. Physiology. 2005, 20: 271-284. 10.1152/physiol.00017.2005.
He A, Liu X, Liu L, Chang Y, Fang F: How many signals impinge on GLUT4 activation by insulin?. Cell Signal. 2007, 19: 1-7. 10.1016/j.cellsig.2006.05.018.
Ferrannini E, Haffner SM, Mitchell BD, Stern M: Hyperinsulinemia: the key feature of a cardiovesular and metabolic syndrome. Diabetologia. 1991, 34: 416-422. 10.1007/BF00403180.
Koopmans SJ, Ohaman L, Haywood JR, Mandarino LJ, DeFronzo RA: Seven days of euglycemic hyperinsulinemia induces insulin resistance for glucose metabolism but not hypertension, elevated catecholamine levels, or increased sodium retention in conscious normal rates. Diabetes. 1997, 46: 1572-1578. 10.2337/diabetes.46.10.1572.
Seely LB, Olefsky JM: Potential cellular and genetic mechanisms for insulin resistance in the common disorders of diabetes and obesity. Insulin resistance. Edited by: Moller DE. 1993, New York: Wiley, 187-252.
Kumar N, Dey CS: Development of insulin resistance and reversal by thiazolidinediones in C2C12 skeletal muscle cells. Biochem Pharmacol. 2003, 65: 249-257. 10.1016/S0006-2952(02)01509-5.
Bisht B, Goel HL, Dey CS: Focal adhesion kinase regulates insulin resistance in skeletal muscle. Diabetologia. 2007, 50: 1058-1069. 10.1007/s00125-007-0591-6.
Tsakiridis T, Vranic M, Klip A: Disassembly of the actin network inhibits insulin-dependent stimulation of glucose transport and prevents recruitment of glucose transporters to the plasma membrane. J Biol Chem. 1994, 269: 29934-29942.
Patel N, Rudich A, Khayat ZA, Garg R, Klip A: Intracellular segregation of phosphatidyinositol-3,4,5-trisphosphate by insulin-dependent actin remodeling in L6 skeletal muscle cells. Mol Cell Biol. 2003, 23: 4611-4626. 10.1128/MCB.23.13.4611-4626.2003.
Vollenweider P, Martin SS, Haruta T, Morris AJ, Nelson JG, Cormont M, Marchand-Brustel YL, Rose DW, Olefsky JM: The small guanosine triphosphate-binding protein Rab4 is involved in insulin-induced GLUT4 translocation and actin filament rearrangement in 3T3-L1 cells. Endocrinology. 1997, 138: 4941-4949. 10.1210/en.138.11.4941.
Huang J, Imamura T, Babendure JL, Lu JC, Olefsky JM: Disruption of microtubules ablates the specificity of insulin signaling to GLUT4 translocation in 3T3-L1 adipocytes. J Biol Chem. 2005, 280: 42300-42306. 10.1074/jbc.M510920200.
Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A: The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell. 1992, 70: 401-410. 10.1016/0092-8674(92)90164-8.
Omata W, Shibata H, Li L, Takata K, Kojima I: Actin filaments play a critical role in insulin-induced exocytotic recruitment but not in endocytosis of GLUT4 in isolated rat adipocytes. Biochem J. 2000, 346: 321-328. 10.1042/0264-6021:3460321.
Kanzaki M, Pessin JE: Insulin-stimulated GLUT4 translocation in adipocytes is dependent upon cortical actin remodeling. J Biol Chem. 2001, 276: 42436-42444. 10.1074/jbc.M108297200.
Brozinick JT, Hawkins ED, Strawbridge AB, Elmendorf JS: Disruption of cortical actin in skeletal muscle demonstrates an essential role of the cytoskeleton in glucose transporter 4 translocation in insulin-sensitive tissues. J Biol Chem. 2004, 279: 40699-40706. 10.1074/jbc.M402697200.
Knight JB, Yamauchi K, Pessin JE: Divergent insulin and platelet-derived growth factor regulation of focal adhesion kinase (pp125FAK) tyrosine phosphorylation, and rearrangement of actin stress fibers. J Biol Chem. 1995, 270: 10199-10203. 10.1074/jbc.270.17.10199.
Palazzo AF, Eng CH, Schlaepfer DD, Marcantonio EE, Gundersen GG: Localized stabilization of microtubules by integrin- and FAK- facilitated Rho signaling. Science. 2004, 303: 836-839. 10.1126/science.1091325.
Wang Q, Bilan PJ, Klip A: Opposite effects of insulin on focal adhesion proteins in 3T3-L1 adipocytes and in cells overexpressing the insulin receptor. Mol Biol Cell. 1998, 9: 3057-3069.
Schober M, Raghavan S, Nikolova M, Polak L, Pasolli HA, Beggs HE, Reichardt LF, Fuchs E: Focal adhesion kinase modulates tension signaling to control actin and focal adhesion dynamics. J Cell Biol. 2007, 176: 667-680. 10.1083/jcb.200608010.
Nedachi T, Kanzaki M: Regulations of glucose transporters by insulin and extracellular glucose in C2C12 myotubes. Am J Physiol Endocrinol Metab. 2006, 291: E817-E828. 10.1152/ajpendo.00194.2006.
Li D, Randhawa V, Patel N, Hayashi M, Klip A: Hyperosmolarity reduces GLUT4 endocytosis and increases its exocytosis from a VAMP2-independent pool in L6 muscle cells. J Biol Chem. 2001, 276: 22883-22891. 10.1074/jbc.M010143200.
Fletcher LM, Welsh GI, Oatey PB, Tavare JM: Role for the microtubule cytoskeleton in GLUT4 vesicle trafficking and in the regulation of insulin-stimulated glucose uptake. Biochem J. 2000, 352: 267-276. 10.1042/0264-6021:3520267.
Ishiki M, Klip A: Recent developments in the regulation of glucose transporter-4 traffic: new signals, locations, and partners. Endocrinology. 2005, 146: 5071-5078. 10.1210/en.2005-0850.
Huang D, Kohe M, Ilic D, Bryer-Ash M: Reduced expression of focal adhesion kinase disrupts insulin action in skeletal muscle cells. Endocrinology. 2006, 147: 3333-3343. 10.1210/en.2005-0382.
Wang QH, Bilan PJ, Tsakiridis T, Hinek A, Klip A: Actin filaments participate in the relocalization of phosphatidylinositol 3-kinase to glucose transporter-containing compartments and in the stimulation of glucose uptake in 3T3-L1 adipocytes. Biochem J. 1998, 331: 917-928.
Emoto M, Langille SE, Czech MP: A role for kinesin in insulin stimulated GLUT4 glucose transporter translocation in 3T3-L1 adipocytes. Biol Chem. 2001, 276: 10677-10682. 10.1074/jbc.M010785200.
Tsakiridis T, Tong P, Matthews B, Tsiani E, Bilan PJ, Klip A, Downey GP: Role of the actin cytoskeleton in insulin action. Microsc Res Tech. 1999, 47: 79-92. 10.1002/(SICI)1097-0029(19991015)47:2<79::AID-JEMT1>3.0.CO;2-S.
McCarthy AM, Spisak KO, Brozinick JT, Elmendrof JS: Loss of cortical actin filaments in insulin-resistant skeletal muscle cells impairs Glut-4 vesicle trafficking and glucose transport. Am J Physiol Cell Physiol. 2006, 291: C860-C868. 10.1152/ajpcell.00107.2006.
Kiehne K, Herzig KH, Folsch UR: Regulation of the actin cytoskeleton by p125 focal adhesion kinase in rat pancreatic acinar cells. Digestion. 1999, 60: 153-160. 10.1159/000007641.
Schlaepfer DD, Mitra SK: Multiple connections link FAK to cell motility and invasion. Curr Opin Genetics Dev. 2004, 14: 92-101. 10.1016/j.gde.2003.12.002.
Khayat ZA, Tong P, Yaworsky K, Bloch RJ, Klip A: Insulin induced actin filament remodeling colocalizes actin with phosphatidylinositol 3-kinase and GLUT4 in L6 myotubes. J Cell Sci. 2000, 113: 279-290.
Jiang ZY, Chawla A, Bose A, Way M, Czech MP: A phosphatidylinositol 3-kinase-independent insulin signaling pathway to N-WASP/Arp2/3/F-actin required for GLUT4 glucose transporter recycling. J Biol Chem. 2002, 277: 509-515. 10.1074/jbc.M108280200.
Saltiel AR, Pessin JE: Insulin signaling in microdomains of the plasma membrane. Traffic. 2003, 4: 711-716. 10.1034/j.1600-0854.2003.00119.x.
Oatey PB, Venkateswarlu K, Williams AG, Fletcher LM, Foulstone EJ, Cullen PJ, Tavare JM: Confocal imaging of the subcellular distribution of phosphatidylinositol 3,4,5-trisphosphate in insulin- and PDGF-stimulated 3T3-L1 adipocytes. Biochem J. 1999, 344: 511-518. 10.1042/0264-6021:3440511.
Martin SS, Rose DW, Saltiel AR, Klippel A, Williams LT, Olefsky JM: Phosphatidylinositol 3-kinase is necessary and sufficient for insulin-stimulated stress fiber breakdown. Endocrinology. 1996, 137: 5045-5054. 10.1210/en.137.11.5045.
Liu LZ, Zhao HL, Zuo J, Ho SKS, Chan JCN, Meng Y, Fang FD, Tong PCY: Protein kinase Cζ mediates insulin-induced glucose transport through actin remodeling in L6 muscle cells. Mol Biol Cell. 2006, 17: 2322-2330. 10.1091/mbc.E05-10-0969.
Khurana A, Dey CS: Subtype specific roles of mitogen activated protein kinases in L6E9 skeletal muscle cell differentiation. Mol Cell Biochem. 2002, 238: 27-39. 10.1023/A:1019957602038.
We thank Dr. H. Blau, Stanford University, School of Medicine, Stanford, U.S.A. and Dr. J. Dhawan, CCMB, India for providing us C2C12 mouse skeletal muscle cell line. We greatly acknowledge Dr. D.D. Schlaepfer of the Scripps Research Institute, La Jolla, CA, USA for providing pcDNA3.1-HA-FAKwt plasmid and Dr. Jeremy M. Tavare of the University of Bristol, UK for providing pcDNA3-GFP-Glut-4 plasmid as a kind gift. B. Bisht was a recipient of Senior Research Fellowship from the Council of Scientific and Industrial Research, Government of India, New Delhi. This study was supported by a grant from the Department of Biotechnology, Government of India, New Delhi (BT/HRD/34/04/2004, dated 30.4.2004).
The authors declare that they have no competing interests.
BB designed and executed experiments, analysed data and drafted the manuscript. CSD conceived the study, designed, coordinated experiments, written and finalized the manuscript. All authors read and approved the final manuscript.